The Pan Probe Biotech, Inc., LiveSure^TM Morphine Screen Test is an in vitro diagnostic (IVD), qualitative, lateral flow, immunochromatographic urinary assay for the rapid detection of morphine in human urine at the cut-off level of 300 ng/ml.  Opiates, such as morphine, heroin, and codeine, are derived from the resin of opium poppy.  Heroin and codeine are metabolized to morphine.  Thus, the presence metabolite in urine indicates heroin, codeine and/or morphine use.  Morphine is the primary urinary marker for detecting opiate use.  The LiveSure^TM Morphine Screen Test is a competitive immunoassay in which chemically modified and bound morphine conjugate competes with urinary morphine and its metabolites (morphine glucuronide) for limited, specific morphine antibody binding sites.  Each test device contains a sample reaction unit, a pink-colored, antibody-colloidal gold conjugate unit pre-labeled with specific antibody, and a chromatographic membrane pre-coated with drug conjugate in the device test region.